M Palatnik
Overview
Explore the profile of M Palatnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brance M, Pons-Estel B, Quagliato N, Jorfen M, Berbotto G, Cortese N, et al.
Osteoporos Int
. 2020 Sep;
32(4):705-714.
PMID: 32974730
Introduction: To evaluate cortical and trabecular bone involvement of the hip in RA patients by dual-energy X-ray absorptiometry (DXA) and 3D analysis. The secondary end-point was to evaluate bone involvement...
2.
SantAnna Gomes B, Estalote A, Palatnik M, Pimenta G, Pereira B, Do Nascimento E
Transfus Med
. 2010 Jun;
20(5):303-14.
PMID: 20553427
Objective/aim: The aim of this study is to describe the distribution of the platelet blood group A antigenicity in Euro-Brazilians (EUBs) and Afro-Brazilians (AFBs). Background: A small but significant proportion...
3.
Borja-Cabrera G, Santos F, Santos F, Trivellato F, Kawasaki J, Costa A, et al.
Vaccine
. 2009 Oct;
28(3):597-603.
PMID: 19800443
Leishmune, the first licensed vaccine for prophylaxis against canine visceral leishmaniasis (CVL) and is also immunotherapeutic when used with double saponin adjuvant concentration. The Leishmune therapeutic vaccine was assessed for...
4.
Santos F, Borja-Cabrera G, Miyashiro L, Grechi J, Reis A, Moreira M, et al.
Vaccine
. 2007 Jul;
25(33):6176-90.
PMID: 17630055
In order to assess the immunotherapeutic potential on canine visceral leishmaniasis of the Leishmune vaccine, formulated with an increased adjuvant concentration (1mg of saponin rather than 0.5mg), 24 mongrel dogs...
5.
Nico D, Santos F, Borja-Cabrera G, Palatnik M, Palatnik de Sousa C
Vaccine
. 2006 Oct;
25(4):649-58.
PMID: 17014936
The CP05 saponin from Calliandra pulcherrima Benth, shows remarkable similarities to the QS21 saponin of Quillaja saponaria Molina. Both shared a monoterpene hydrophobic moiety, a glycidic chain attached to the...
6.
Oliveira-Freitas E, Casas C, Borja-Cabrera G, Santos F, Nico D, Souza L, et al.
Vaccine
. 2006 Mar;
24(18):3909-20.
PMID: 16556475
The adjuvant of the FML-vaccine against murine and canine visceral leishmaniasis, the Riedel de Haen saponin mixture, was fractionated by ion exchange chromatography on DEAE-cellulose to afford one TLC homogeneous...
7.
Palatnik de Sousa C, Santos W, Casas C, Paraguai de Souza E, Tinoco L, da Silva B, et al.
Vaccine
. 2004 Jun;
22(19):2470-9.
PMID: 15193411
The presence of aldehyde groups at C-23 and C-24 of the triterpen aglycon moiety was disclosed in 1H NMR spectra of both the Riedel de Haen saponin (R) (delta 9.336)...
8.
Estalote A, Palatnik M, Chester M, Olsson M, SantAnna Gomes B
Transfus Med
. 2004 Apr;
14(2):173-80.
PMID: 15113382
A discrepancy in the ABO blood groups between a newborn child and her parents was identified. Serological and DNA investigative techniques were performed. A weak variant of B (B(w)) was...
9.
Borja-Cabrera G, Correia Pontes N, da Silva V, Paraguai de Souza E, Santos W, GOMES E, et al.
Vaccine
. 2002 Sep;
20(27-28):3277-84.
PMID: 12213397
Naturally exposed dogs of an endemic area were vaccinated with the fucose mannose ligand (FML) antigen of Leishmania donovani in formulation with QuilA saponin. The 100% of vaccinees were seropositive...
10.
Palatnik-de-Sousa C, dos Santos W, Franca-Silva J, da Costa R, Reis A, Palatnik M, et al.
Am J Trop Med Hyg
. 2001 Nov;
65(5):510-7.
PMID: 11716106
Brazil is the only country endemic for zoonotic visceral leishmaniasis (ZVL) that regularly conducts epidemiologic and prophylactic control programs that involve the treatment of human cases, insect vector control, and...